{
    "title": "114_hr3717",
    "content": "The Act is titled the \"U.S.-Israel Global Neuroscience Partnership Act\" and includes findings related to the partnership. The \"U.S.-Israel Global Neuroscience Partnership Act\" emphasizes the importance of developing neuroscience research and neurotechnology for national security. It acknowledges Israel as a strong ally and highlights four bilateral R&D foundations for cooperation. The United States and Israel aim to strengthen research, high-technology, and innovation ties in strategic areas of mutual interest. Both governments are working towards an umbrella Science & Technology Agreement to enhance science and technology collaboration beyond existing bilateral foundations. Congress supports this agreement and its implementation through Federal R&D and innovation programs. The State of Israel has a centralized mechanism for policy and funding industrial R&D through the Office of the Chief Scientist. The U.S.-Israel Joint Economic Development Group aims to enhance cooperation through the United States-Israel Science & Technology Foundation. Israel Brain Technologies is a nonprofit organization leading research in neuroscience, aiming to make Israel a global hub for brain technology. Enhanced cooperation between the United States and Israel in neuroscience research is beneficial for both countries. Congress supports expanding U.S.-Israel industry R&D through innovation linkages for economic growth. Regular dialogue with Israel's OCS aims to coordinate bilateral cooperation in R&D programs. SEC. 3. GRANTS FOR NEUROSCIENCE-RELATED RESEARCH. The Secretary of Health and Human Services, in consultation with government counterparts, will award grants for neuroscience research and technological innovation. Eligible entities must submit applications meeting specified criteria for grant selection. The Secretary will award grants for neuroscience research and innovation through the SBIR and STTR programs. Grant amounts will be determined by the Secretary in consultation with relevant committees. Private funds can be accepted for this purpose. Recipients must submit reports on fund usage and project success within 180 days of receiving the grant. The U.S.-Israel Neuroscience Advisory Committee is established. The U.S.-Israel Neuroscience Advisory Committee is established within the National Institutes of Health. It advises the Secretary on grant criteria and total grant amounts, with membership consisting of 3 members appointed by the NIH Director and 3 Israeli citizens appointed after consultation. The U.S.-Israel Neuroscience Advisory Committee is established within the National Institutes of Health. The initial appointments should be made within 60 days of the Act's enactment, with members serving for 4 years. Vacancies will be filled in the same manner as the original appointment. Members serve without pay but receive travel expenses. The U.S.-Israel Neuroscience Advisory Committee shall meet annually with a quorum of three members. The Chairperson is appointed by the Director of the National Institutes of Health. The Committee is exempt from termination under the Federal Advisory Committee Act. SEC. 5. DEFINITIONS. In this Act, the term \"Advisory Committee\" refers to the U.S.-Israel Neuroscience Advisory Committee. The term \"eligible entity\" refers to a joint venture comprised of Israeli and United States private business entities, academic persons, and carrying out an eligible project. The term \"eligible project\" refers to a project promoting cooperation between the US and Israel in neuroscience research and technological innovation. An \"Israeli academic person\" includes higher education institutions, subsidiaries, affiliates in Israel, or individuals conducting research for these entities. An eligible project promotes cooperation between the US and Israel in neuroscience research and technological innovation. A United States academic person is defined as an institution of higher education, its subsidiaries or affiliates, or an individual conducting research for them, residing and working in Israel. The term \"Secretary\" refers to the Secretary of Health and Human Services. An eligible project promotes cooperation between the US and Israel in neuroscience research and technological innovation. A United States academic person is defined as an institution of higher education, its subsidiaries or affiliates, or an individual conducting research for them, residing and working in Israel. The term \"Secretary\" refers to the Secretary of Health and Human Services. The individual must be an employee or contractor residing and working in the United States. SEC. 6. TERMINATION. The grant program and Advisory Committee will end after a 7-year period from the enactment of this Act. SEC. 7. AUTHORIZATION OF APPROPRIATIONS. The Secretary can spend up to $20,000,000 annually from 2016 to 2022 to implement this Act."
}